These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24916696)

  • 1. Twisting and ironing: doxorubicin cardiotoxicity by mitochondrial DNA damage.
    Nitiss KC; Nitiss JL
    Clin Cancer Res; 2014 Sep; 20(18):4737-9. PubMed ID: 24916696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity.
    Khiati S; Dalla Rosa I; Sourbier C; Ma X; Rao VA; Neckers LM; Zhang H; Pommier Y
    Clin Cancer Res; 2014 Sep; 20(18):4873-81. PubMed ID: 24714774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthracycline-induced cardiotoxicity.
    Ferreira AL; Matsubara LS; Matsubara BB
    Cardiovasc Hematol Agents Med Chem; 2008 Oct; 6(4):278-81. PubMed ID: 18855640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity.
    Ohlig J; Henninger C; Zander S; Merx M; Kelm M; Fritz G
    Arch Toxicol; 2018 Jan; 92(1):441-453. PubMed ID: 28710503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mice overexpressing metallothionein are not resistant to adriamycin cardiotoxicity.
    DiSilvestro RA; Liu J; Klaassen CD
    Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):163-70. PubMed ID: 8884987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A colorful chemotherapy agent could be made less toxic.
    Kaiser J
    Science; 2020 Jul; 369(6499):18. PubMed ID: 32631876
    [No Abstract]   [Full Text] [Related]  

  • 7. Short-term doxorubicin cardiotoxic effects: involvement of cardiac Thyrotropin Releasing Hormone system.
    Peres Diaz LS; Schuman ML; Aisicovich M; Toblli JE; Pirola CJ; Landa MS; García SI
    Life Sci; 2020 Nov; 261():118346. PubMed ID: 32853656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
    Forrest GL; Gonzalez B; Tseng W; Li X; Mann J
    Cancer Res; 2000 Sep; 60(18):5158-64. PubMed ID: 11016643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA FOXC2-AS1 protects cardiomyocytes from doxorubicin-induced cardiotoxicity through activation of WNT1-inducible signaling pathway protein-1.
    Zhang S; Yuan Y; Zhang Z; Guo J; Li J; Zhao K; Qin Y; Qiu C
    Biosci Biotechnol Biochem; 2019 Apr; 83(4):653-658. PubMed ID: 30558506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
    Gyöngyösi M; Lukovic D; Zlabinger K; Spannbauer A; Gugerell A; Pavo N; Traxler D; Pils D; Maurer G; Jakab A; Riesenhuber M; Pircher A; Winkler J; Bergler-Klein J
    Cardiovasc Res; 2020 Apr; 116(5):970-982. PubMed ID: 31346605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of mitochondrial membrane potential prevents doxorubicin-induced cardiotoxicity in isolated rat heart.
    Montaigne D; Marechal X; Baccouch R; Modine T; Preau S; Zannis K; Marchetti P; Lancel S; Neviere R
    Toxicol Appl Pharmacol; 2010 May; 244(3):300-7. PubMed ID: 20096298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
    Sun X; Zhou Z; Kang YJ
    Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin.
    Govender J; Loos B; Marais E; Engelbrecht AM
    J Pineal Res; 2014 Nov; 57(4):367-80. PubMed ID: 25230823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic heart damage following doxorubicin treatment is alleviated by lovastatin.
    Henninger C; Huelsenbeck S; Wenzel P; Brand M; Huelsenbeck J; Schad A; Fritz G
    Pharmacol Res; 2015 Jan; 91():47-56. PubMed ID: 25462173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of doxorubicin-induced cardiotoxicity in a human in vitro cardiac model by the induction of the NRF-2 pathway.
    Tomlinson L; Lu ZQ; Bentley RA; Colley HE; Murdoch C; Webb SD; Cross MJ; Copple IM; Sharma P
    Biomed Pharmacother; 2019 Apr; 112():108637. PubMed ID: 30798127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthracycline cardiotoxicity in transgenic mice overexpressing SR Ca2+-ATPase.
    Burke BE; Olson RD; Cusack BJ; Gambliel HA; Dillmann WH
    Biochem Biophys Res Commun; 2003 Apr; 303(2):504-7. PubMed ID: 12659846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
    Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
    Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
    Li M; Sala V; De Santis MC; Cimino J; Cappello P; Pianca N; Di Bona A; Margaria JP; Martini M; Lazzarini E; Pirozzi F; Rossi L; Franco I; Bornbaum J; Heger J; Rohrbach S; Perino A; Tocchetti CG; Lima BHF; Teixeira MM; Porporato PE; Schulz R; Angelini A; Sandri M; Ameri P; Sciarretta S; Lima-Júnior RCP; Mongillo M; Zaglia T; Morello F; Novelli F; Hirsch E; Ghigo A
    Circulation; 2018 Aug; 138(7):696-711. PubMed ID: 29348263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
    Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
    Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multiscale Physiologically-Based Pharmacokinetic Model for Doxorubicin to Explore its Mechanisms of Cytotoxicity and Cardiotoxicity in Human Physiological Contexts.
    He H; Liu C; Wu Y; Zhang X; Fan J; Cao Y
    Pharm Res; 2018 Jul; 35(9):174. PubMed ID: 29987398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.